Calamos Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-277,808	Closed	-$16.3M	–	1033
2023 Q4	$16.3M	Buy	+277,808	New	+$16.3M	0.08%	284
2021 Q1	–	Sell	-13,103	Closed	-$2.88M	–	943
2020 Q4	$2.88M	Sell	13,103 -6,433	-33%	-$1.41M	0.02%	565
2020 Q3	$3.24M	Buy	+19,536	New	+$3.24M	0.02%	501